Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (251-260 of 953) with videos related to

Pageof 96
Sort By:
Brain Communications|March 21, 2022
Grey matter network markers identify individuals with prodromal Alzheimer's disease who will show rapid clinical declineWiesje Pelkmans, Ellen M Vromen, Ellen Dicks, et al.
Neurobiology of Aging|April 21, 2020
Degree of genetic liability for Alzheimer's disease associated with specific proteomic profiles in cerebrospinal fluidLianne M Reus, Sven Stringer, Danielle Posthuma, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 22, 2007
Evaluation of methods for generating parametric (R-[11C]PK11195 binding imagesAlie Schuitemaker, Bart N M van Berckel, Marc A Kropholler, et al.
Journal of Neurology|May 8, 2002
Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjectsPieter Jelle Visser, Frans R J Verhey, Philip Scheltens, et al.
Frontiers in Aging Neuroscience|May 25, 2017
MRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and DiagnosisHanneke F M Rhodius-Meester, Marije R Benedictus, Mike P Wattjes, et al.
Journal of Proteome Research|March 3, 2020
Fingerprinting Alzheimer's Disease by <sup>1</sup>H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal FluidAlessia Vignoli, Silvia Paciotti, Leonardo Tenori, et al.
International Journal of Geriatric Psychiatry|April 21, 2023
The clock drawing test is an important contribution to the Mini Mental State Examination in screening for cognitive impairmentCaroline C Claus, Salka S Staekenborg, Kim H W Verweij, et al.
BMC Neurology|August 21, 2015
Declining functional connectivity and changing hub locations in Alzheimer's disease: an EEG studyMarjolein M A Engels, Cornelis J Stam, Wiesje M van der Flier, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Lumbar puncture in patients with neurologic conditionsRosha Babapour Mofrad, Femke H Bouwman, Rosalinde E R Slot, et al.
Dementia and Geriatric Cognitive Disorders|June 29, 2007
Cognitive impairment in Alzheimer's disease is modified by APOE genotypeAnnelies E van der Vlies, Yolande A L Pijnenburg, Teddy Koene, et al.
Pageof 96

Showing results (251-260 of 953) with videos related to

Sort By:
Pageof 96
Brain Communications|March 21, 2022
Grey matter network markers identify individuals with prodromal Alzheimer's disease who will show rapid clinical declineWiesje Pelkmans, Ellen M Vromen, Ellen Dicks, et al.
Neurobiology of Aging|April 21, 2020
Degree of genetic liability for Alzheimer's disease associated with specific proteomic profiles in cerebrospinal fluidLianne M Reus, Sven Stringer, Danielle Posthuma, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 22, 2007
Evaluation of methods for generating parametric (R-[11C]PK11195 binding imagesAlie Schuitemaker, Bart N M van Berckel, Marc A Kropholler, et al.
Journal of Neurology|May 8, 2002
Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjectsPieter Jelle Visser, Frans R J Verhey, Philip Scheltens, et al.
Frontiers in Aging Neuroscience|May 25, 2017
MRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and DiagnosisHanneke F M Rhodius-Meester, Marije R Benedictus, Mike P Wattjes, et al.
Journal of Proteome Research|March 3, 2020
Fingerprinting Alzheimer's Disease by <sup>1</sup>H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal FluidAlessia Vignoli, Silvia Paciotti, Leonardo Tenori, et al.
International Journal of Geriatric Psychiatry|April 21, 2023
The clock drawing test is an important contribution to the Mini Mental State Examination in screening for cognitive impairmentCaroline C Claus, Salka S Staekenborg, Kim H W Verweij, et al.
BMC Neurology|August 21, 2015
Declining functional connectivity and changing hub locations in Alzheimer's disease: an EEG studyMarjolein M A Engels, Cornelis J Stam, Wiesje M van der Flier, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Lumbar puncture in patients with neurologic conditionsRosha Babapour Mofrad, Femke H Bouwman, Rosalinde E R Slot, et al.
Dementia and Geriatric Cognitive Disorders|June 29, 2007
Cognitive impairment in Alzheimer's disease is modified by APOE genotypeAnnelies E van der Vlies, Yolande A L Pijnenburg, Teddy Koene, et al.
Pageof 96